5 Stocks That Moved the Most in 2025 – What Lies Ahead
at www.tipranks.com (Tue, 23-Dec 4:18 PM)
These Are the Most and Least Likely Biotech Takeover Targets for 2026
at www.tipranks.com (Tue, 23-Dec 2:37 PM)
Here are the most and least likely M&A targets in biotech, according to Truist
at seekingalpha.com (Tue, 23-Dec 1:26 PM)
at www.tipranks.com (Tue, 23-Dec 7:20 AM)
Abivax is the top performing biotechnology stock YTD
at seekingalpha.com (Mon, 22-Dec 4:07 PM)
UniFirst, Adeia, Cytokinetics And Other Big Stocks Moving Higher On Monday
at www.benzinga.com (Mon, 22-Dec 10:56 AM)
Top 10 healthcare stocks according to YTD performance, as the sector holds steady
at seekingalpha.com (Mon, 22-Dec 9:59 AM)
Biggest stock movers Monday: ABVX, RKLB, UNF, and more
at seekingalpha.com (Mon, 22-Dec 9:53 AM)
Why Is Abivax (ABVX) Stock Rallying Today?
at www.tipranks.com (Mon, 22-Dec 6:34 AM)
Why Is Abivax (ABVX) Stock Rallying Today? Big Pharma Takeover Buzz Builds
at www.tipranks.com (Mon, 22-Dec 6:34 AM)
Why Clearwater Analytics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
at www.benzinga.com (Mon, 22-Dec 6:00 AM)
Biggest stock movers Monday: ABVX, RKLB, and more
at seekingalpha.com (Mon, 22-Dec 4:54 AM)
Obefazimod Shows Potential Anti-Fibrotic Effect as Abivax Presents Expansive Data at ECCO 2026
Market Chameleon (Thu, 18-Dec 8:46 AM)
Abivax Extends Cash Runway to Q4 2027 After Public Offering Bolsters Financial Position
Market Chameleon (Tue, 16-Dec 7:06 AM)
Abivax's Obefazimod Shows Promising Patient-Reported Outcomes in Ulcerative Colitis Phase 3 Trials
Market Chameleon (Tue, 4-Nov 7:22 AM)
Market Chameleon (Mon, 6-Oct 7:08 AM)
Abivax to Unveil Phase 3 Obefazimod Results for Ulcerative Colitis at UEG 2025
Market Chameleon (Wed, 24-Sep 7:09 AM)
